Advanced search
Publication Cover
Leukemia & Lymphoma Volume 35, 1999 - Issue 5-6
Submit an article Journal homepage
41
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Mitoxantrone-DHAP with GM-CSF: An Active but Myelosuppressive Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma

Rashida Haq Division of Hematology/Oncology, St. Michael's Hospital, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada
,
Carol A. Sawka Divisions of Medical Oncology/Hematology, University of Toronto, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada; Department of Public Health Sciences, University of Toronto, Toronto, CanadaCorrespondence[email protected]
,
Edmée Franssen Clinical Trials and Epidemiology, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Canada; Department of Public Health Sciences, University of Toronto, Toronto, Canada
&
Neil L. Berinstein Divisions of Medical Oncology/Hematology, University of Toronto, Toronto, Canada; Department of Medicine, University of Toronto, Toronto, Canada; Department of Immunology, University of Toronto, Toronto, Canada
Pages 527-536 | Received 15 Oct 1998, Published online: 30 Mar 2010

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Johannes Atta, Kai U. Chow, Eckhart Weidmann, Paris S. Mitrou, Dieter Hoelzer & Hans Martin. (2007) Dexa-BEAM as salvage therapy in patients with primary refractory aggressive Non-Hodgkin lymphoma. Leukemia & Lymphoma 48:2, pages 349-356.
Read now

Articles from other publishers (9)

Julie E. Chang, Songwong Seo, Kyungmann M. Kim, Jae E. Werndli, Wayne A. Bottner, Gilberto A. Rodrigues, Federico A. Sanchez, Thomas J. Saphner, Walter L. Longo & Brad S. Kahl. (2010) Rituximab and CHOP Chemotherapy Plus GM-CSF for Previously Untreated Diffuse Large B-Cell Lymphoma in the Elderly: A Wisconsin Oncology Network Study. Clinical Lymphoma Myeloma and Leukemia 10:5, pages 379-384.
Crossref
Carsten Zwick, Josef Birkmann, Norma Peter, Heinrich Bodenstein, Roland Fuchs, Mathias Hänel, Marcel Reiser, Manfred Hensel, Michael Clemens, Samira Zeynalova, Marita Ziepert & Michael Pfreundschuh. (2008) Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone). Annals of Hematology 87:9, pages 717-726.
Crossref
A Spencer, K Reed & C Arthur. (2007) Pilot study of an outpatient-based approach for advanced lymphoma using vinorelbine, gemcitabine and filgrastim. Internal Medicine Journal 0:0, pages 070602000936001-???.
Crossref
Muge Yemisci, Sibel Bozdag, Meltem Çetin, Figen Söylemezoglu, Yilmaz Çapan, Turgay Dalkara & Imran Vural. (2006) TREATMENT OF MALIGNANT GLIOMAS WITH MITOXANTRONE-LOADED POLY (LACTIDE-CO-GLYCOLIDE) MICROSPHERES. Neurosurgery 59:6, pages 1296-1303.
Crossref
A. Josting, C. Rudolph, M. Reiser, M. Mapara, M. Sieber, H.H. Kirchner, B. Dörken, D.K. Hossfeld, V. Diehl & A. Engert. (2002) Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease. Annals of Oncology 13:10, pages 1628-1635.
Crossref
Luis Villela, Armando L�pez-Guillermo, Silvia Montoto, Susana Rives, Francesc Bosch, Mar�a Perales, Ana Ferrer, Jordi Esteve, Lluis Colomo, El�as Campo & Emilio Montserrat. (2001) Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens. Cancer 91:8, pages 1557-1562.
Crossref
Ralph J. Hauke & James O. Armitage. (2000) Treatment of non-Hodgkin lymphoma. Current Opinion in Oncology 12:5, pages 412-418.
Crossref
Kathleen Kaysinger. (2000) The 41st Annual Meeting of the American Society of Hematology, New Orleans, LA December 3–7, 1999. Clinical Lymphoma 1:1, pages 17-26.
Crossref
. (2000) Current Awareness. Hematological Oncology 18:2, pages 77-84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.